(Q83196313)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19148794%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Cyclooxygenase-2 inhibitors in patients with high gastrointestinal risk: are we there yet? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19148794%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19148794%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Vincent Wai-Sun Wong

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19148794%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

16 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19148794%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19148794%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

44 Suppl 19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19148794%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

53-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19148794%20AND%20SRC:MED&resulttype=core&format=json

Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study

19 January 2020

cites work

1 reference

12 December 2020

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

12 December 2020

Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?

1 reference

12 December 2020

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

12 December 2020

Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review

1 reference

12 December 2020

Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly

1 reference

12 December 2020

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

1 reference

12 December 2020

Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

1 reference

12 December 2020

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.

1 reference

12 December 2020

Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient

1 reference

12 December 2020

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

1 reference

12 December 2020

Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy

1 reference

12 December 2020

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis

1 reference

12 December 2020

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

12 December 2020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

12 December 2020

The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

NSAIDs, risks, and gastroprotective strategies: current status and future

1 reference

12 December 2020

Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo

1 reference

12 December 2020

10.1007/S00535-008-2260-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19148794%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference